141 related articles for article (PubMed ID: 11742223)
1. Central injection of interleukin-13 potentiates LPS-induced sickness behavior in rats.
Bluthé RM; Bristow A; Lestage J; Imbs C; Dantzer R
Neuroreport; 2001 Dec; 12(18):3979-83. PubMed ID: 11742223
[TBL] [Abstract][Full Text] [Related]
2. Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide-induced sickness behavior in rats.
Bluthé RM; Lestage J; Rees G; Bristow A; Dantzer R
Neuropsychopharmacology; 2002 Jan; 26(1):86-93. PubMed ID: 11751035
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat.
Castanon N; Bluthé RM; Dantzer R
Psychopharmacology (Berl); 2001 Feb; 154(1):50-60. PubMed ID: 11292006
[TBL] [Abstract][Full Text] [Related]
4. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats.
Bluthé RM; Castanon N; Pousset F; Bristow A; Ball C; Lestage J; Michaud B; Kelley KW; Dantzer R
Psychoneuroendocrinology; 1999 Apr; 24(3):301-11. PubMed ID: 10101735
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice.
Bluthé RM; Layé S; Michaud B; Combe C; Dantzer R; Parnet P
Eur J Neurosci; 2000 Dec; 12(12):4447-56. PubMed ID: 11122355
[TBL] [Abstract][Full Text] [Related]
6. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide.
Konsman JP; Veeneman J; Combe C; Poole S; Luheshi GN; Dantzer R
Eur J Neurosci; 2008 Dec; 28(12):2499-510. PubMed ID: 19087175
[TBL] [Abstract][Full Text] [Related]
7. Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist.
Kent S; Kelley KW; Dantzer R
Neurosci Lett; 1992 Sep; 145(1):83-6. PubMed ID: 1461574
[TBL] [Abstract][Full Text] [Related]
8. The putative JAK-STAT inhibitor AG490 exacerbates LPS-fever, reduces sickness behavior, and alters the expression of pro- and anti-inflammatory genes in the rat brain.
Damm J; Harden LM; Gerstberger R; Roth J; Rummel C
Neuropharmacology; 2013 Aug; 71():98-111. PubMed ID: 23548702
[TBL] [Abstract][Full Text] [Related]
9. Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1beta.
Bret-Dibat JL; Creminon C; Couraud JY; Kelley KW; Dantzer R; Kent S
Brain Res Bull; 1997; 42(6):443-9. PubMed ID: 9128919
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior.
Harden LM; du Plessis I; Poole S; Laburn HP
Physiol Behav; 2006 Sep; 89(2):146-55. PubMed ID: 16842830
[TBL] [Abstract][Full Text] [Related]
11. Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice.
Bluthé RM; Michaud B; Poli V; Dantzer R
Physiol Behav; 2000; 70(3-4):367-73. PubMed ID: 11006436
[TBL] [Abstract][Full Text] [Related]
12. Role of corticosterone in the behavioral effects of central interleukin-1 beta.
Propes MJ; Johnson RW
Physiol Behav; 1997 Jan; 61(1):7-13. PubMed ID: 8976527
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity of lurcher mutant mice to the depressing effects of lipopolysaccharide and interleukin-1 on behaviour.
Bluthé RM; Michaud B; Delhaye-Bouchaud N; Mariani J; Dantzer R
Neuroreport; 1997 Mar; 8(5):1119-22. PubMed ID: 9175096
[TBL] [Abstract][Full Text] [Related]
14. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice.
Dantzer R; Gheusi G; Johnson RW; Kelley KW
Neuroreport; 1999 Feb; 10(2):289-92. PubMed ID: 10203323
[TBL] [Abstract][Full Text] [Related]
15. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release.
Russo E; Andreozzi F; Iuliano R; Dattilo V; Procopio T; Fiume G; Mimmi S; Perrotti N; Citraro R; Sesti G; Constanti A; De Sarro G
Brain Behav Immun; 2014 Nov; 42():157-68. PubMed ID: 24998197
[TBL] [Abstract][Full Text] [Related]
16. Defect in interleukin-1beta secretion prevents sickness behavior in C3H/HeJ mice.
Segreti J; Gheusi G; Dantzer R; Kelley KW; Johnson RW
Physiol Behav; 1997 Jun; 61(6):873-8. PubMed ID: 9177560
[TBL] [Abstract][Full Text] [Related]
17. C3H/HeJ mice are refractory to lipopolysaccharide in the brain.
Johnson RW; Gheusi G; Segreti S; Dantzer R; Kelley KW
Brain Res; 1997 Mar; 752(1-2):219-26. PubMed ID: 9106460
[TBL] [Abstract][Full Text] [Related]
18. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat.
Bluthé RM; Dantzer R; Kelley KW
Brain Res; 1992 Feb; 573(2):318-20. PubMed ID: 1387028
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1 beta production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis.
Di Santo E; Sironi M; Pozzi P; Gnocchi P; Isetta AM; Delvaux A; Goldman M; Marchant A; Ghezzi P
Neuroimmunomodulation; 1995; 2(3):149-54. PubMed ID: 8646564
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma potentiates interleukin (IL)-6 and tumor necrosis factor-alpha but not IL-1beta induced by endotoxin in the brain.
De Simoni MG; Terreni L; Chiesa R; Mangiarotti F; Forloni GL
Endocrinology; 1997 Dec; 138(12):5220-6. PubMed ID: 9389504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
